Lampasona V - Search Results

1

Association of IA-2 autoantibodies with HLA DR4 phenotypes in IDDM.

Genovese S, Bonfanti R, Bazzigaluppi E, Lampasona V, Benazzi E, Bosi E, Chiumello G, Bonifacio E. Genovese S, et al. Among authors: lampasona v. Diabetologia. 1996 Oct;39(10):1223-6. doi: 10.1007/BF02658510. Diabetologia. 1996. PMID: 8897011

2

Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity.

Bonifacio E, Genovese S, Braghi S, Bazzigaluppi E, Lampasona V, Bingley PJ, Rogge L, Pastore MR, Bognetti E, Bottazzo GF, et al. Bonifacio E, et al. Among authors: lampasona v. Diabetologia. 1995 Jul;38(7):816-22. doi: 10.1007/s001250050358. Diabetologia. 1995. PMID: 7556984

3

HLA DQA1-DQB1-TAP2 haplotypes in IDDM families: no evidence for an additional contribution to disease risk by the TAP2 locus.

Esposito L, Lampasona V, Bosi E, Poli F, Ferrari M, Bonifacio E. Esposito L, et al. Among authors: lampasona v. Diabetologia. 1995 Aug;38(8):968-74. doi: 10.1007/BF00400587. Diabetologia. 1995. PMID: 7589884

4

Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies.

Bonifacio E, Lampasona V, Genovese S, Ferrari M, Bosi E. Bonifacio E, et al. Among authors: lampasona v. J Immunol. 1995 Dec 1;155(11):5419-26. J Immunol. 1995. PMID: 7594559

5

Sera from patients with IDDM and healthy individuals have antibodies to ICA69 on western blots but do not immunoprecipitate liquid phase antigen.

Lampasona V, Ferrari M, Bosi E, Pastore MR, Bingley PJ, Bonifacio E. Lampasona V, et al. J Autoimmun. 1994 Oct;7(5):665-74. doi: 10.1006/jaut.1994.1051. J Autoimmun. 1994. PMID: 7840858

6

Autoantibodies to glutamic acid decarboxylase in palatal myoclonus and epilepsy.

Nemni R, Braghi S, Natali-Sora MG, Lampasona V, Bonifacio E, Comi G, Canal N. Nemni R, et al. Among authors: lampasona v. Ann Neurol. 1994 Oct;36(4):665-7. doi: 10.1002/ana.410360419. Ann Neurol. 1994. PMID: 7944301

7

HLA-DQ screening for risk assessment of insulin dependent diabetes in northern Italy.

Lampasona V, Ferrari M, Bonifacio E, Pastore MR, Carrera P, Sergi A, Genovese S, Trucco M, Dorman J, Bosi E. Lampasona V, et al. Acta Diabetol. 1995 Oct;32(3):137-42. doi: 10.1007/BF00838481. Acta Diabetol. 1995. PMID: 8590780

8

Islet cell autoantigen 69 antibodies in IDDM.

Martin S, Lampasona V, Dosch M, Pietropaolo M. Martin S, et al. Among authors: lampasona v. Diabetologia. 1996 Jun;39(6):747. doi: 10.1007/BF00418550. Diabetologia. 1996. PMID: 8781774 No abstract available.

9

Autoantibodies in insulin-dependent diabetes recognize distinct cytoplasmic domains of the protein tyrosine phosphatase-like IA-2 autoantigen.

Lampasona V, Bearzatto M, Genovese S, Bosi E, Ferrari M, Bonifacio E. Lampasona V, et al. J Immunol. 1996 Sep 15;157(6):2707-11. J Immunol. 1996. PMID: 8805677

10

Lack of association of DMB polymorphism with insulin-dependent diabetes.

Esposito L, Lampasona V, Bonifacio E, Bosi E, Ferrari M. Esposito L, et al. Among authors: lampasona v. J Autoimmun. 1997 Aug;10(4):395-400. doi: 10.1006/jaut.1997.0144. J Autoimmun. 1997. PMID: 9237803

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters